LPSN Form 4: Anthony Zingale receives 400k-share option, 2025 vesting
Rhea-AI Filing Summary
Anthony Zingale, a director of LivePerson, Inc. (LPSN), was granted a stock option on 08/25/2025 to purchase 400,000 shares of common stock at an exercise price of $1.08 per share under the LivePerson, Inc. 2019 Stock Incentive Plan. The option vests in three equal annual installments beginning on the first anniversary of 08/25/2025 and expires on 08/25/2035. Following the grant, the reporting person is shown as beneficially owning the 400,000 underlying shares
Positive
- Director alignment: Grant vests over three years, aligning the director’s incentives with the company’s longer-term performance
- Clear terms disclosed: Exercise price ($1.08), grant date (08/25/2025), vesting schedule, and expiration (08/25/2035) are explicitly stated
Negative
- Potential dilution: The option covers 400,000 shares which could dilute existing shareholders if exercised
- Concentration of award: A single large grant to a director may materially affect executive compensation totals and warrants disclosure
Insights
TL;DR A director received a large option grant that could align incentives but will dilute if exercised.
The 400,000-share option at $1.08 is sizable relative to most equity grants and creates potential future dilution if exercised. Vesting over three years ties retention and performance to continued service for the director. The long expiration to 2035 gives flexibility for exercise timing. The grant itself is not a cash expense today but will impact share count if exercised; investors should note the strike price and vesting schedule when modeling potential dilution.
TL;DR Standard director equity award with multi-year vesting; aligns interests but warrants disclosure review.
The option was granted under the company’s 2019 plan with customary multi-year vesting, indicating alignment of the director’s incentives with long-term shareholder value. The grant date, exercise price of $1.08, and clear vesting schedule are properly disclosed on Form 4. From a governance perspective, the size of the award is material enough to require monitoring of overall equity compensation run rate and cumulative dilution from insider option exercises.